CN117886712A - Isolamine-containing capsaicin compound, and preparation method and application thereof - Google Patents
Isolamine-containing capsaicin compound, and preparation method and application thereof Download PDFInfo
- Publication number
- CN117886712A CN117886712A CN202410034694.4A CN202410034694A CN117886712A CN 117886712 A CN117886712 A CN 117886712A CN 202410034694 A CN202410034694 A CN 202410034694A CN 117886712 A CN117886712 A CN 117886712A
- Authority
- CN
- China
- Prior art keywords
- unsubstituted
- isopropanolamine
- optionally substituted
- capsaicin
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Natural products COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 title claims abstract description 99
- 229960002504 capsaicin Drugs 0.000 title claims abstract description 53
- 235000017663 capsaicin Nutrition 0.000 title claims abstract description 52
- -1 capsaicin compound Chemical class 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims abstract description 38
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 claims abstract description 33
- 229940102253 isopropanolamine Drugs 0.000 claims abstract description 26
- 125000003342 alkenyl group Chemical group 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 241000607479 Yersinia pestis Species 0.000 claims description 13
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 125000001072 heteroaryl group Chemical group 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 125000000304 alkynyl group Chemical group 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 8
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 6
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 6
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 6
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 6
- 229910052805 deuterium Inorganic materials 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 150000002367 halogens Chemical class 0.000 claims description 6
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 6
- 238000006467 substitution reaction Methods 0.000 claims description 6
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 3
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- 125000001831 (C6-C10) heteroaryl group Chemical group 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 239000012453 solvate Substances 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 230000001580 bacterial effect Effects 0.000 abstract description 32
- 240000007594 Oryza sativa Species 0.000 abstract description 20
- 235000007164 Oryza sativa Nutrition 0.000 abstract description 20
- 235000009566 rice Nutrition 0.000 abstract description 20
- 241000894006 Bacteria Species 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 15
- 239000000575 pesticide Substances 0.000 abstract description 15
- 230000005764 inhibitory process Effects 0.000 abstract description 12
- 241000207199 Citrus Species 0.000 abstract description 11
- 235000020971 citrus fruits Nutrition 0.000 abstract description 11
- 244000000005 bacterial plant pathogen Species 0.000 abstract description 8
- 235000002566 Capsicum Nutrition 0.000 abstract description 7
- 244000298697 Actinidia deliciosa Species 0.000 abstract description 6
- 235000009436 Actinidia deliciosa Nutrition 0.000 abstract description 6
- 240000008067 Cucumis sativus Species 0.000 abstract description 6
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 abstract description 6
- 235000021307 Triticum Nutrition 0.000 abstract description 6
- 244000157072 Hylocereus undatus Species 0.000 abstract description 4
- 235000018481 Hylocereus undatus Nutrition 0.000 abstract description 4
- 241000233622 Phytophthora infestans Species 0.000 abstract description 4
- 206010039509 Scab Diseases 0.000 abstract description 4
- 240000000851 Vaccinium corymbosum Species 0.000 abstract description 4
- 235000003095 Vaccinium corymbosum Nutrition 0.000 abstract description 4
- 235000017537 Vaccinium myrtillus Nutrition 0.000 abstract description 4
- 241000082085 Verticillium <Phyllachorales> Species 0.000 abstract description 4
- 235000021014 blueberries Nutrition 0.000 abstract description 4
- 239000006002 Pepper Substances 0.000 abstract description 3
- 235000016761 Piper aduncum Nutrition 0.000 abstract description 3
- 235000017804 Piper guineense Nutrition 0.000 abstract description 3
- 235000008184 Piper nigrum Nutrition 0.000 abstract description 3
- 241000221662 Sclerotinia Species 0.000 abstract description 3
- 235000002597 Solanum melongena Nutrition 0.000 abstract description 3
- 244000061458 Solanum melongena Species 0.000 abstract description 3
- 240000002791 Brassica napus Species 0.000 abstract 1
- 235000006008 Brassica napus var napus Nutrition 0.000 abstract 1
- 244000203593 Piper nigrum Species 0.000 abstract 1
- 241000224016 Plasmodium Species 0.000 abstract 1
- 244000098338 Triticum aestivum Species 0.000 abstract 1
- 244000000004 fungal plant pathogen Species 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 12
- 230000000844 anti-bacterial effect Effects 0.000 description 11
- 239000002609 medium Substances 0.000 description 10
- 125000001424 substituent group Chemical group 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 239000004495 emulsifiable concentrate Substances 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 230000002538 fungal effect Effects 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 230000003032 phytopathogenic effect Effects 0.000 description 6
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 5
- 240000008574 Capsicum frutescens Species 0.000 description 5
- 241000233866 Fungi Species 0.000 description 5
- 241000209140 Triticum Species 0.000 description 5
- 230000000843 anti-fungal effect Effects 0.000 description 5
- 125000002619 bicyclic group Chemical group 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 125000005842 heteroatom Chemical group 0.000 description 5
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000001965 potato dextrose agar Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 241000222122 Candida albicans Species 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 239000001390 capsicum minimum Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 210000002421 cell wall Anatomy 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 4
- 229960004884 fluconazole Drugs 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241001290235 Ceratobasidium cereale Species 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 240000006365 Vitis vinifera Species 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 239000003899 bactericide agent Substances 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 125000001188 haloalkyl group Chemical group 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 125000002950 monocyclic group Chemical group 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000012827 research and development Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 2
- AKDLSISGGARWFP-UHFFFAOYSA-N Homodihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCCCC(C)C)=CC=C1O AKDLSISGGARWFP-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920002752 Konjac Polymers 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 235000003228 Lactuca sativa Nutrition 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- JYZDUDMWJFJCON-UHFFFAOYSA-N N-[(4-Hydroxy-3-methoxyphenyl)methyl]octanamide Chemical compound CCCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 JYZDUDMWJFJCON-UHFFFAOYSA-N 0.000 description 2
- VQEONGKQWIFHMN-UHFFFAOYSA-N Nordihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCC(C)C)=CC=C1O VQEONGKQWIFHMN-UHFFFAOYSA-N 0.000 description 2
- 240000003889 Piper guineense Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 241000813090 Rhizoctonia solani Species 0.000 description 2
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000021186 dishes Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 2
- 230000008686 ergosterol biosynthesis Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- GOBFKCLUUUDTQE-UHFFFAOYSA-N homodihydrocapsaicin-II Natural products CCC(C)CCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 GOBFKCLUUUDTQE-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 235000010485 konjac Nutrition 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 125000006168 tricyclic group Chemical group 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 239000004562 water dispersible granule Substances 0.000 description 2
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 description 1
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- 125000006729 (C2-C5) alkenyl group Chemical group 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 1
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000006041 3-hexenyl group Chemical group 0.000 description 1
- 125000006042 4-hexenyl group Chemical group 0.000 description 1
- 125000003119 4-methyl-3-pentenyl group Chemical group [H]\C(=C(/C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- RSNWORHVUOZYLT-UHFFFAOYSA-N 5-[[(2-sulfanylidene-3h-1,3,4-thiadiazol-5-yl)amino]methylamino]-3h-1,3,4-thiadiazole-2-thione Chemical compound S1C(=S)NN=C1NCNC1=NNC(=S)S1 RSNWORHVUOZYLT-UHFFFAOYSA-N 0.000 description 1
- 125000006043 5-hexenyl group Chemical group 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 241000223600 Alternaria Species 0.000 description 1
- 239000005740 Boscalid Substances 0.000 description 1
- 241000123650 Botrytis cinerea Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 235000002567 Capsicum annuum Nutrition 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 241000221955 Chaetomium Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241001330975 Magnaporthe oryzae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 241000256259 Noctuidae Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241000233616 Phytophthora capsici Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 241000520892 Xanthomonas axonopodis Species 0.000 description 1
- 241000907138 Xanthomonas oryzae pv. oryzae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000004450 alkenylene group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 125000004419 alkynylene group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 description 1
- 229940118790 boscalid Drugs 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- OSVHLUXLWQLPIY-KBAYOESNSA-N butyl 2-[(6aR,9R,10aR)-1-hydroxy-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-3-yl]-2-methylpropanoate Chemical compound C(CCC)OC(C(C)(C)C1=CC(=C2[C@H]3[C@H](C(OC2=C1)(C)C)CC[C@H](C3)CO)O)=O OSVHLUXLWQLPIY-KBAYOESNSA-N 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001735 carboxylic acids Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000004617 chromonyl group Chemical group O1C(=CC(C2=CC=CC=C12)=O)* 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125851 compound 27 Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 210000003074 dental pulp Anatomy 0.000 description 1
- 125000004188 dichlorophenyl group Chemical group 0.000 description 1
- XJQPQKLURWNAAH-UHFFFAOYSA-N dihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCCC(C)C)=CC=C1O XJQPQKLURWNAAH-UHFFFAOYSA-N 0.000 description 1
- RBCYRZPENADQGZ-UHFFFAOYSA-N dihydrocapsaicin Natural products COC1=CC(COC(=O)CCCCCCC(C)C)=CC=C1O RBCYRZPENADQGZ-UHFFFAOYSA-N 0.000 description 1
- 125000004611 dihydroisoindolyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000006379 fluoropyridyl group Chemical group 0.000 description 1
- 239000005003 food packaging material Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 238000004896 high resolution mass spectrometry Methods 0.000 description 1
- JKIHLSTUOQHAFF-UHFFFAOYSA-N homocapsaicin Natural products COC1=CC(CNC(=O)CCCCCC=CC(C)C)=CC=C1O JKIHLSTUOQHAFF-UHFFFAOYSA-N 0.000 description 1
- MLJGZARGNROKAC-VQHVLOKHSA-N homocapsaicin Chemical compound CCC(C)\C=C\CCCCC(=O)NCC1=CC=C(O)C(OC)=C1 MLJGZARGNROKAC-VQHVLOKHSA-N 0.000 description 1
- JZNZUOZRIWOBGG-UHFFFAOYSA-N homocapsaicin-II Natural products COC1=CC(CNC(=O)CCCCC=CCC(C)C)=CC=C1O JZNZUOZRIWOBGG-UHFFFAOYSA-N 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 230000028644 hyphal growth Effects 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Chemical group COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000009728 shiwei Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 150000003459 sulfonic acid esters Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
- 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- MBNMHBAJUNHZRE-UHFFFAOYSA-M thiosultap monosodium Chemical compound [Na+].OS(=O)(=O)SCC(N(C)C)CSS([O-])(=O)=O MBNMHBAJUNHZRE-UHFFFAOYSA-M 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention relates to the technical field of pharmaceutical chemistry, in particular to a capsaicin compound containing isopropanolamine, a preparation method and application thereof, wherein the compound has a structure shown in a general formula (I):
Description
Technical Field
The invention belongs to the technical field of pharmaceutical chemistry, and particularly relates to a capsaicin compound containing isopropanolamine, a preparation method and application thereof.
Background
Bacterial and fungal plant diseases such as bacterial leaf blight of rice, bacterial wilt of capsicum, leaf spot of cabbage, bacterial wilt of tobacco, citrus canker, kiwi fruit canker, gray mold of cucumber, pepper wilt, sclerotium of rape, wheat scab, late blight of potato, root rot of blueberry, chaetomium, anthracnose of dragon fruit, rice sheath blight and the like, can cause the host plant to show symptoms such as necrosis, wilt and rot, bring about huge economic loss to crops in the world each year, and cause crop yield reduction of up to 60% -75% in serious cases. Chemical control is easy to operate, has low cost and is still the most effective mode for controlling the plant, but a series of problems such as environmental pollution, agricultural residues, damage to human health and the like are caused by unreasonable use of traditional pesticides for a long time, and drug resistance of plant pathogenic microorganisms is caused, so that drug-resistant plants are generated. Thus, there is an urgent need to develop a novel bactericide which has high activity, high selectivity and no cross resistance with existing pesticides.
Natural products play an important role in the development of pesticides. It is reported that the novel active ingredient in conventional pesticides is mostly derived from natural products and has a proportion of about 66.4%. In addition, the botanical pesticide has the advantages of being ecological, high in safety, various in action mode, wide in adaptability and the like, and is favored in the research and development of new pesticides. Capsaicin and its derivatives are reported to have a wide range of biological activities, such as antifungal, antibacterial, herbicidal, antitumor, antiviral, etc. At present, various efficient pesticides containing capsaicin structure play an important role in plant disease and pest control. Isopropanolamine structures are widely used in the fields of pesticides and medicines, such as antagonists, bactericides, antihyperglycemic agents, antimalarial agents and the like, and contain the isopropanolamine structure. More importantly, the previous study of the subject group revealed that the isopropanolamine structure-containing derivatives all exhibit excellent antibacterial activity by being able to be linked to different precursor precursors.
In order to find an efficient antibacterial active compound, the invention takes capsaicin as a guide, introduces an isopropanolamine skeleton, designs and synthesizes a series of capsaicin derivatives containing isopropanolamine structures, tests the bioactivity of the capsaicin derivatives, and provides an important scientific basis for the research and development and the creation of new pesticides.
The study of the biological activity of capsaicin compounds has progressed as follows:
akyuz et al [ Akyuz L., kaya M., mujoba M., ilk S., sargin I., salaverria A.M., labidi J., cakmak Y.S., islek C.supporting capsaicin with chitosan-based films enhanced theanti-quorum sensing, anti-biological, tranpany elasticity and hydrophobicity [ J ]. International Journal of Biological Macromolecules,2018,115:438-446 ] found capsaicin to have biological functions of high antioxidant, anti-inflammatory, weight loss, anticancer and analgesic properties, for the first time, for use in membrane technology. Chitosan (as a common animal-based polymer) was blended with capsaicin at three different concentrations to obtain an edible film. Films were characterized by FT-IR, SEM, DSC et al. Mechanical, transmittance, hydrophobicity, anti-quorum sensing, antibacterial and antioxidant properties were also examined. The optimal concentration for enhancing three membrane properties (including mechanical, optical and surface morphology) was observed by incorporating 0.6mg capsaicin into a chitosan matrix (200 mg dissolved in 1% acetic acid solution). As the capsaicin concentration in the film increased, continued improvements in anti-quorum and antimicrobial activity, oxidation resistance and hydrophobicity were noted. In further studies, chitosan-capsaicin blend films are useful as food packaging materials as well as skin and wound healing patches.
In 2020, wang et al [ Rongang Wang, yang Liu, shiwei Sun, yueyue Si, xaoohong Liu, xaoxoian Liu, shuang Zhang,. Capsaicinoids from hot pepper (Capsicum annuum L.) and theirphytotoxic effect on seedling growth of lettuce (Laxuca sativa L.) [ J ]. Natural product research,2020,34,1597-1601 ] isolated a series of capsaicin compounds from Capsicum fruits by semi-preparative high performance liquid chromatography: N-vanillyl-4E, 6E-diene-8-methylnonanamide, capsaicin, dihydrocapsaicin, N-vanillyl octanamide, nordihydrocapsaicin, N-vanillyl decanoamide, homocapsaicin, N-vanillyl-4, 8-dimethylacrylamide homodihydrocapsaicin II, homodihydrocapsaicin II and homodihydrocapsaicin I. The isolated compounds were structurally characterized by comparison of spectroscopic data with literature data. Biological assay results show that the capsaicin compound can obviously shorten the radicle length of lettuce seedlings, and the inhibition effect has dose dependency.
In 2022 Xie et al (Dandan Xie, zaiping Yang, xin Hu, yin Wen. Synthesis, antibacterial, andInsecticidal Activities of Novel Capsaicin Derivatives Containing a Sulfonic Acid Esters Moiety [ J ] front. Chem.2022,10,929050.) developed a series of capsaicin derivatives containing sulfonate structures. Their structure is characterized by nuclear magnetic resonance spectroscopy and high resolution mass spectrometry. The results of biological activity indicate that some target compounds have significant antibacterial activity. At 50 mug/mL, the compound 3b shows the most excellent activity on kiwifruit canker, rice bacterial leaf blight and citrus canker, and the inhibition rates are 86, 54 and 92 percent respectively, which are higher than those of commercial drugs thiabendazole (87, 34 and 77 percent) and bismerthiazol (87, 37 and 75 percent). In addition, although some compounds have some inhibitory effect on the noctuid, they are weaker than the positive control monosultap. Thus, bioassay results suggest that these newly designed and synthesized scaffolds may act as lead compounds for biocidal compounds rather than pesticides.
In 2023 Behbehani et al [ Behbehani J.M., irshad M., shreaz S., karched M. Anti-microbial activity of capsaicin and its effect on ergosterol biosynthesis and membrane integrity of Candidaalbicans [ J ]. International Journal of Molecular Sciences,2023,24,1046 ] studied the antifungal sensitivity of capsaicin as an active ingredient in capsicum. Capsaicin and fluconazole sensitivity to Candida albicans was tested using the CLSI (M27-A3) method. The effect of capsaicin on fungal cell walls was examined by ergosterol inhibition and observed by scanning electron microscopy, with the lowest inhibitory concentration of capsaicin on 30 strains of C.stomatitis, 8 strains of C.dental pulp and 2 strains of ATCC candida ranging from 12.5-50 μg/mL. After combination with capsaicin (MIC/4), the MIC range of fluconazole (128-4. Mu.g/mL) is significantly reduced (2-4 fold). Capsaicin (MIC) significantly reduces the mature biofilm of candida albicans by 70% to 89%. With increasing capsaicin dose, the ergosterol content of the cell wall decreases significantly. Capsaicin exhibits a high sensitivity to hyphal formation, exhibiting a reduction of over 71% in mature biofilms. Fluorescence microscopy revealed a capsaicin-treated candida albicans cell membrane disruption, while electron microscopy images revealed a distorted cell shape, a broken cell wall, and cell shrinkage after release of the cell contents. The results indicate that capsaicin has potential antifungal activity, inhibits ergosterol biosynthesis in the cell wall, and thus disrupts the structure and integrity of the cell. More importantly, capsaicin synergistically enhances the antifungal activity of fluconazole, and the synergistic effect can be helpful for preventing the development of fluconazole drug resistance and reducing the dosage.
Disclosure of Invention
In order to solve the technical problems, the invention provides a capsaicin compound containing isopropanolamine, and a preparation method and application thereof.
In order to achieve the above purpose, the invention provides an isopropanolamine-containing capsaicin compound, which has a structure shown in a general formula (I):
wherein,
R 1 one or more selected from capsaicin parent C9 alkyl, C9 alkenyl, benzoyl, acetyl, propionyl, butyryl and acryloyl;
R 2 and R is 3 Identical or different, R 2 And R is 3 Independently selected from one or more of hydrogen, deuterium, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted alkynyl, optionally substituted or unsubstituted alkoxy, optionally substituted or unsubstituted cycloalkyl, optionally substituted or unsubstituted aryl, optionally substituted or unsubstituted heteroaryl.
According to the invention, capsaicin and isopropanolamine structures are taken as pharmacophores, and two pharmacophores are connected through different bridging chains to synthesize a series of capsaicin derivatives containing isopropanolamine, and the compounds have excellent inhibition effects on plant pathogenic bacteria such as bacterial blight bacteria of rice, canker bacteria of citrus, bacterial strip spot bacteria of rice, canker bacteria of kiwi fruits and the like, thus providing an important scientific basis for developing and creating new pesticides.
Preferably, R 2 And R is 3 Identical or different, R 2 And R is 3 Independently selected from one or more of hydrogen, deuterium, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 alkoxy, substituted or unsubstituted C6-C15 aryl, substituted or unsubstituted C6-C10 heteroaryl;
wherein the substitution refers to substitution with one or more of C1-C6 alkyl, C1-C6 alkoxy, amino, hydroxy, halogen, nitro and trifluoromethyl.
More preferably, R 2 And R is 3 Identical or different, R 2 And R is 3 Independently selected from:
preferably, the isopropanolamine-containing capsaicin compound is selected from the following compounds:
the invention also provides an intermediate compound for preparing the isopropanolamine-containing capsaicin compound, which has a structural formula shown in formula (II):
R 1 one or more selected from capsaicin parent C9 alkyl, C9 alkenyl, benzoyl, acetyl, propionyl, butyryl and acryloyl.
The invention also provides a preparation method of the capsaicin compound containing isopropanolamine, which comprises the following synthetic route:
R 1 one or more selected from capsaicin parent C9 alkyl, C9 alkenyl, benzoyl, acetyl, propionyl, butyryl and acryloyl;
R 2 and R is 3 Identical or different, R 2 And R is 3 Independently selected from one or more of hydrogen, deuterium, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted alkynyl, optionally substituted or unsubstituted alkoxy, optionally substituted or unsubstituted cycloalkyl, optionally substituted or unsubstituted aryl, optionally substituted or unsubstituted heteroaryl.
The invention also provides a composition, the active ingredient of which is the capsaicin compound containing isopropanolamine or the stereoisomer thereof, or the salt thereof or the solvate thereof, and the composition also comprises an agriculturally usable auxiliary agent or bactericide, pesticide or herbicide.
Preferably, the formulation of the composition is selected from the group consisting of Emulsifiable Concentrates (EC), powders (DP), wettable Powders (WP), granules (GR), aqueous Solutions (AS), suspensions (SC), ultra low volume sprays (ULV), soluble Powders (SP), microcapsules (MC), smoke agents (FU), aqueous Emulsions (EW) or water dispersible granules (WG).
The invention also provides application of the isopropanolamine-containing capsaicin compound or the composition in the aspect of controlling agricultural diseases and insect pests. Preferably, the agricultural pest is a bacterial or fungal plant disease; more preferably, the agricultural pest is a plant leaf blight and a plant canker; most preferably, the agricultural pest is rice bacterial leaf blight, cucumber bacterial leaf blight, konjak bacterial leaf blight, citrus canker, tobacco bacterial wilt, grape canker, tomato canker, kiwi fruit canker, apple canker, cucumber gray mold, capsicum blight, rape sclerotinia, wheat scab, potato late blight, blueberry root rot, grape vine cavity bacteria, dragon fruit anthracnose or rice sheath blight.
A method for controlling agricultural pests, which comprises allowing the isopropanolamine-containing capsaicin compound or the composition to act on harmful substances or living environments thereof. Preferably, the agricultural pest is a bacterial or fungal plant disease; more preferably, the agricultural pest is rice bacterial leaf blight, cucumber bacterial leaf blight, konjak bacterial leaf blight, citrus canker, tobacco bacterial wilt, grape canker, tomato canker, kiwi canker, apple canker, cucumber gray mold, pepper blight, rape sclerotinia, wheat scab, potato late blight, blueberry root rot, viticola, dragon fruit anthracnose, rice sheath blight or eggplant verticillium wilt.
A method for protecting plants from agricultural pests, allowing said isopropanolamine-containing capsaicin compound or said composition to act on the plants or their living environment.
The term "alkyl" as used herein is intended to include both branched and straight chain saturated hydrocarbon groups having a specified number of carbon atoms. For example "C 1-10 Alkyl "(or alkylene) is intended to mean C1, C2, C3, C4, C5, C6, C7, C8, C9 and C10 alkyl. In addition, e.g. "C 1-6 Alkyl "means an alkyl group having 1 to 6 carbon atoms. Alkyl groups may be unsubstituted or substituted such that one or more of its hydrogen atoms is replaced by another chemical group. Examples of alkyl groups include, but are not limited to, methyl (Me), ethyl (Et), propyl (e.g., n-propyl and isopropyl), butyl (e.g., n-butyl, isobutyl, t-butyl), pentyl (e.g., n-pentyl, isopentyl, neopentyl) and the like.
"alkenyl" is a hydrocarbon that includes both straight or branched chain structures and has one or more carbon-carbon double bonds that occur at any stable point in the chain. For example "C 2-6 Alkenyl "(or alkenylene) is intended to include C2, C3, C4, C5 and C6 alkenyl groups. Examples of alkenyl groups include, but are not limited to, vinyl, 1-propenyl, 2-butenyl, 3-butenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 2-methyl-2-propenyl, 4-methyl-3-pentenyl and the like.
"alkynyl" is a hydrocarbon that includes both straight or branched chain structures and has one or more carbon-carbon triple bonds that occur at any stable point in the chain. For example "C 2-6 Alkynyl "(or alkynylene) is intended to include C2, C3, C4, C5, and C6 alkynyl; such as ethynyl, propynyl, butynyl, pentynyl, hexynyl, and the like.
The term "substituted" as used herein refers to any one or more hydrogen atoms on a specified atom or group being replaced with a selected specified group, provided that the specified atom's general valency is not exceeded. Substituents are named to the central structure, unless otherwise indicated. For example, it is understood that when (cycloalkyl) alkyl is the possible substituent, the point of attachment of the substituent to the central structure is in the alkyl moiety. As used herein, a ring double bond is a double bond formed between two adjacent ring atoms (e.g., c= C, C =n or n=n). When referring to substitution, particularly polysubstituted, it is meant that a plurality of substituents are substituted at various positions on the indicated group, e.g. dichlorophenyl refers to 1, 2-dichlorophenyl, 1, 3-dichlorophenyl, 1, 4-dichlorophenyl and 2, 4-dichlorophenyl.
Combinations of substituents and or variables are permissible only if such combinations result in stable compounds or useful synthetic intermediates. The stable compound or stable structure implies that the compound is sufficiently stable when isolated from the reaction mixture in useful purity, and is formulated to form an effective therapeutic agent. Preferably, the compounds at present do not comprise N-halogen, S (O) 2 H or S (O) H group.
The term "aryl" refers to a monocyclic or bicyclic aromatic hydrocarbon group having 6 to 12 carbon atoms in the ring portion, such as phenyl and naphthyl, each of which may be substituted.
The term "halogen" or "halogen atom" refers to chlorine, bromine, fluorine and iodine.
The term "haloalkyl" refers to a substituted alkyl group having one or more halogen substituents. For example, "haloalkyl" includes mono-, di-and trifluoromethyl; even though the halo in the haloalkyl is explicitly fluoro, chloro, bromo, iodo, it also refers to substituted alkyl groups having one or more fluoro, chloro, bromo, iodo substituents.
The term "heteroaryl" refers to substituted and unsubstituted aromatic 5-or 6-membered monocyclic groups, 9-or 10-membered bicyclic groups, and 11 to 14-membered tricyclic groups, having at least one heteroatom (O, S or N) in at least one ring, said heteroatom-containing ring preferably having 1,2 or 3 heteroatoms selected from O, S and N. Each ring of the heteroatom-containing heteroaryl group may contain one or two oxygen or sulfur atoms and/or from 1 to 4 nitrogen atoms provided that the total number of heteroatoms in each ring is 4 or less and that each ring has at least one carbon atom. The fused ring completing the bicyclic and tricyclic groups may contain only carbon atoms and may be saturated, partially saturated, or unsaturated. The nitrogen and sulfur atoms may optionally be oxidized and the nitrogen atoms may optionally be quaternized. Bicyclic or tricyclic heteroaryl groups must include at least one wholly aromatic ring and the nitrogen other fused rings may be aromatic or non-aromatic. Heteroaryl groups may be attached at any available nitrogen or carbon atom of any ring. When the valency permits, if the other ring is cycloalkyl or heterocycle, it is additionally optionally substituted with =o (oxygen).
Exemplary monocyclic heteroaryl groups include pyrrolyl, pyrazolyl, pyrazolinyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, thiadiazolyl, furanyl, thienyl, oxadiazolyl, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, and the like.
Exemplary bicyclic heteroaryl groups include indolyl, spirocyclic ketone, benzodioxolyl, benzoxazolyl, benzothienyl, quinolinyl, tetrahydroisoquinolinyl, isoquinolinyl, benzimidazolyl, benzofuranyl, indolizinyl, benzofuranyl, chromonyl, coumarin, benzofuranyl, cinnolinyl, quinoxalinyl, indazolyl, pyrrolopyridinyl, fluoropyridyl, dihydroisoindolyl, tetrahydroquinolinyl, and the like.
The compounds of the present invention are understood to include both the free form and salts thereof, unless otherwise indicated. The term "salt" means an acid and/or base salt formed from inorganic and/or organic acids and bases. In addition, the term "salt" may include zwitterionic (inner salts), such as when the compounds of formula I contain basic moieties such as amine or pyridine or imidazole rings, and acidic moieties such as carboxylic acids. Pharmaceutically acceptable (i.e., non-toxic, physiologically acceptable) salts are preferred, such as acceptable metal and amine salts, wherein the cation does not contribute significantly to the toxicity or bioactivity of the salt. However, other salts may be useful, such as by employing isolation or purification steps in the preparation process, and are therefore also included within the scope of the present invention.
Preferably, C1-C10 alkyl refers to methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl and isomers thereof; C1-C10 alkoxy means methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, heptoxy, octoxy, nonoxy, decyloxy and isomers thereof; C2-C5 alkenyl refers to ethenyl, propenyl, allyl, butenyl, pentenyl and isomers thereof.
When referring to substituents as alkenyl, alkynyl, alkyl, halogen, aryl, heteroaryl, alkoxy, cycloalkyl, hydroxy, amino, mercapto, phosphino, or when referring to such substituents as in particular to a particular alkenyl, alkynyl, alkyl, halogen, aryl, heteroaryl, alkoxy, cycloalkyl, hydroxy, amino, mercapto, phosphino, one to three of the above substituents are meant. For example methylphenyl refers to one to three methyl-substituted phenyl groups.
Compared with the prior art, the invention has the following advantages and technical effects:
the invention synthesizes a series of capsaicin derivatives containing isopropanolamine based on capsaicin compounds, and discovers that the series of compounds have good inhibition effect on plant pathogenic bacteria, have good inhibition effect on pathogenic bacteria (such as rice bacterial blight bacteria (Xanthomonas oryzae pv. Oryzae, xoo), citrus canker bacteria (Xanthomonas axonopodis pv. Citr, xac) and the like), and provide important scientific basis for the research and development and creation of new pesticides.
Detailed Description
Various exemplary embodiments of the invention will now be described in detail, which should not be considered as limiting the invention, but rather as more detailed descriptions of certain aspects, features and embodiments of the invention.
It is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. In addition, for numerical ranges in this disclosure, it is understood that each intermediate value between the upper and lower limits of the ranges is also specifically disclosed. Every smaller range between any stated value or stated range, and any other stated value or intermediate value within the stated range, is also encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention. All documents mentioned in this specification are incorporated by reference for the purpose of disclosing and describing the methods and/or materials associated with the documents. In case of conflict with any incorporated document, the present specification will control.
It will be apparent to those skilled in the art that various modifications and variations can be made in the specific embodiments of the invention described herein without departing from the scope or spirit of the invention. Other embodiments will be apparent to those skilled in the art from consideration of the specification of the present invention. The specification and examples of the present invention are exemplary only.
As used herein, the terms "comprising," "including," "having," "containing," and the like are intended to be inclusive and mean an inclusion, but not limited to.
The technical means used in the examples are conventional means well known to those skilled in the art unless otherwise indicated. All the starting materials and solvents used in the examples are commercially available products.
The technical scheme of the invention is further illustrated by the following examples.
Example 1 preparation of intermediate 1
Capsaicin analog (5.0 g,0.01704 mol) and anhydrous K 2 CO 3 (4.71 g,0.03408 mol) was added to 50mL of N, N-Dimethylformamide (DMF), stirred at room temperature for 10min, thenBromopropane oxide (2.10 mL,0.02556 mol) was added and stirred overnight. Thereafter, 50mL of ethyl acetate was added to the mixture, and the organic layer was saturated with NH 4 Washing with Cl solution, anhydrous Na 2 SO 4 Drying and vacuum evaporating. By column Chromatography (CH) 2 Cl 2 /CH 3 Oh=100:1, V/V) to give pure intermediate 1. White solid, yield 82.28%;
other epoxy intermediate compounds were synthesized using the corresponding starting materials or substituents, with reference to the procedure of example 1.
EXAMPLE 2N- (4- (3- (cyclopropylamino) -2-hydroxypropoxy) -3-methoxybenzyl) nonanamide, the target compound
Intermediate 1 (0.2 g,0.5720 mmol), cyclopropylamine (0.06335 g,1.1400 mol) and isopropanol (6.0 mL) were added to a 15mL pressure bottle and stirred at 60 ℃ until intermediate 1 was fully reacted. The reaction mixture was extracted with water (20 mL), ethyl acetate (30 mL. Times.2), and the organic layer was extracted with anhydrous Na 2 SO 4 Drying and vacuum evaporating. Target compound uses CH 2 Cl 2 And CH (CH) 3 OH (10:1; V/V) was used as eluent for column chromatography separation and purification. The title compound 1 was obtained as a white solid in 54.15% yield.
Other target compounds were synthesized using the corresponding starting materials or substituents, according to the procedure of example 2.
The structure and nuclear magnetic resonance hydrogen spectrum and carbon spectrum data of the synthesized capsaicin compound containing isopropanolamine are shown in table 1, and the physicochemical properties are shown in table 2.
Table 1 Nuclear magnetic resonance Hydrogen Spectrometry and carbon Spectrometry data for a portion of the Compounds
/>
/>
/>
/>
/>
/>
/>
/>
/>
/>
/>
/>
/>
/>
/>
/>
/>
/>
/>
/>
TABLE 2 physicochemical Properties of the target Compounds
/>
Pharmacological example 1
EC 50 (median effective concentration) is an important index for evaluating the sensitivity of plant pathogenic bacteria to a compound, and is also an important parameter for setting the concentration of the compound when researching the action mechanism of the target compound. In the concentration gradient experiment, proper 5 concentrations are set by adopting a double dilution method, and finally the inhibition rate of the medicament to plant pathogenic bacteria and the medicament concentration are converted into logarithmic values, and the virulence curve is obtained by SPSS software regression analysis, so that EC is calculated 50 。
Testing the effective medium concentration EC of the target compound to plant pathogenic bacteria by using turbidity method 50 The test subjects were rice bacterial leaf blight bacteria (Xoo), citrus canker bacteria (Xac) and rice bacterial leaf streak (Xoc). DMSO was dissolved in the medium as a blank. Putting rice bacterial leaf blight bacteria (rice bacterial leaf blight pathogenic bacteria are in an M210 solid culture medium) into an NB culture medium, and carrying out shake culture in a constant-temperature shaking table at 28 ℃ and 180rpm until the bacterial leaf blight bacteria are in a logarithmic growth phase for later use; placing citrus canker pathogens (on M210 solid medium) into NB medium; the rice bacterial leaf spot bacteria (on M210 solid medium) are put into NB medium and are shake-cultured in a constant temperature shaker at 28 ℃ and 180rpm until logarithmic phase is ready for use. 5mL of toxic NB liquid culture medium with different concentrations (for example, 100,50,25,12.5,6.25 mug/mL) of the medicament (compound) is prepared, and is added into a test tube, 40 mu L of NB liquid culture medium containing phytopathogenic bacteria is respectively added, and the mixture is oscillated in a constant temperature shaking table at 28-30 ℃ and 180rpm, wherein bacterial leaf blight of rice is cultivated for 48 hours, citrus canker is cultivated for 48 hours, and bacterial leaf spot of rice is cultivated for 48 hours. Measuring OD of bacterial solutions with various concentrations on an enzyme-labeled instrument 595 Values, and additionally determining the OD of corresponding concentrations of toxic sterile NB liquid medium 595 Values.
Corrected OD = bacteria-containing medium OD-sterile medium OD
Inhibition ratio = [ (corrected control culture medium bacterial liquid OD value-corrected toxic culture medium OD value)/corrected control culture medium bacterial liquid OD value ] ×100
The present invention is described with the aid of examples, but the contents of examples are not limited thereto, and the experimental results of the target compounds are shown in table 3.
TABLE 3 EC of isopropanolamine-containing capsaicin against phytopathogenic bacteria 50
/>
As can be seen from Table 3, the target compounds showed good inhibitory activity against plant pathogenic bacteria (such as Rhizoctonia solani, rhizoctonia cerealis and Rhizoctonia cerealis) in an in vitro test. In particular, the compounds 26, 25, 19 and 18 have extremely excellent activity against bacterial leaf blight of rice, and EC thereof 50 9.91-18.71 mug/mL; compounds 26, 18, 16 have extremely excellent activity against citrus canker pathogens, their EC 50 7.04-15.40 mug/mL; compound 27 exhibits excellent inhibitory activity against Pyricularia oryzae and EC thereof 50 22.00. Mu.g/mL. Therefore, the compound has great research prospect and can be used for preparing pesticides against plant pathogenic bacteria.
Pharmacological example 2 test of the inhibition of in vitro antibacterial efficacy of Compound 26 against phytopathogenic fungi Using the hyphal growth Rate method
The test subjects of the fungus, botrytis cinerea, rhizoctonia solani, sclerotinia sclerotiorum, verticillium eggplant verticillium and Gibberella wheat take DMSO in sterile distilled water as negative control, and boscalid as positive control.
2.1 Compound 26 was dissolved in DMSO (1.0 mL), then added to 9.0mL of sterile water containing Tween 20 (1%) and then mixed with potato dextrose agar (PDA, 90.0 mL) at a concentration of 25mg/L of Compound 26.
2.2 the stock solution was transferred uniformly to three 9cm diameter petri dishes.
2.3 mycelium dishes of approximately 4mm diameter were then cut from the medium and inoculated aseptically in the middle of the PDA plates.
2.4 plates after inoculation were incubated at 27.+ -. 1 ℃ for 3-5 days with 3 replicates per treatment condition.
2.5 radial growth of fungal colonies was measured and data were statistically analyzed. The bacteriostatic effect was calculated as = [ (C-T)/(C-0.4) ]x100%, where C is the diameter of fungal growth on untreated PDA, T is the diameter of fungal growth on treated PDA, and I is the rate of inhibition.
The present invention is described with the aid of examples, but the contents of examples are not limited thereto, and the experimental results of the target compounds are shown in table 4.
Table 4 inhibition of in vitro antibacterial efficacy of Compound 26 against phytopathogenic fungi, phytophthora capsici, rhizoctonia cerealis, sclerotinia sclerotiorum, verticillium eggplant and Alternaria wheat (percent)
As can be seen from Table 4, compound 26 was inactive against all six phytopathogenic fungi tested at 25mg/L, but the literature reports that compounds containing capsaicin fragments have activity against phytopathogenic fungi, and it can be considered later that the introduction of other active fragments to increase the antifungal activity of the series of compounds broadens its broad spectrum.
The foregoing is merely a preferred embodiment of the present application, but the scope of the present application is not limited thereto, and any changes or substitutions easily conceivable by those skilled in the art within the technical scope of the present application should be covered in the scope of the present application. Therefore, the protection scope of the present application shall be subject to the protection scope of the claims.
Claims (10)
1. An isopropanolamine-containing capsaicin compound is characterized by having a structure shown in a general formula (I):
wherein,
R 1 one or more selected from capsaicin parent C9 alkyl, C9 alkenyl, benzoyl, acetyl, propionyl, butyryl and acryloyl;
R 2 and R is 3 Identical or different, R 2 And R is 3 Independently selected from one or more of hydrogen, deuterium, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted alkynyl, optionally substituted or unsubstituted alkoxy, optionally substituted or unsubstituted cycloalkyl, optionally substituted or unsubstituted aryl, optionally substituted or unsubstituted heteroaryl.
2. Isopropanolamine-containing capsaicinoids according to claim 1, wherein R 2 And R is 3 Identical or different, R 2 And R is 3 Independently selected from one or more of hydrogen, deuterium, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 alkoxy, substituted or unsubstituted C6-C15 aryl, substituted or unsubstituted C6-C10 heteroaryl;
wherein the substitution refers to substitution with one or more of C1-C6 alkyl, C1-C6 alkoxy, amino, hydroxy, halogen, nitro and trifluoromethyl.
3. Isopropanolamine-containing capsaicinoids according to claim 2, wherein R 2 And R is 3 Identical or different, R 2 And R is 3 Independently selected from:
4. the isopropanolamine-containing capsaicin compound according to claim 1, selected from the following compounds:
5. an intermediate compound for preparing the isopropanolamine-containing capsaicin compound according to any one of claims 1-4, wherein the structural formula is shown in formula (II):
R 1 one or more selected from capsaicin parent C9 alkyl, C9 alkenyl, benzoyl, acetyl, propionyl, butyryl and acryloyl.
6. A process for the preparation of the isopropanolamine-containing capsaicin according to any one of claims 1-4, wherein the synthetic route is as follows:
R 1 one or more selected from capsaicin parent C9 alkyl, C9 alkenyl, benzoyl, acetyl, propionyl, butyryl and acryloyl;
R 2 and R is 3 Identical or different, R 2 And R is 3 Independently selected from one or more of hydrogen, deuterium, optionally substituted or unsubstituted alkyl, optionally substituted or unsubstituted alkenyl, optionally substituted or unsubstituted alkynyl, optionally substituted or unsubstituted alkoxy, optionally substituted or unsubstituted cycloalkyl, optionally substituted or unsubstituted aryl, optionally substituted or unsubstituted heteroaryl.
7. A composition comprising as an active ingredient the isopropanolamine-containing capsaicin compound or its stereoisomer or its salt or its solvate according to any one of claims 1 to 4.
8. Use of the isopropanolamine-containing capsaicin compound according to any one of claims 1-4 or the composition according to claim 7 for controlling agricultural pests.
9. A method for controlling agricultural pests, characterized in that the isopropanolamine-containing capsaicin compound according to any one of claims 1 to 4 or the composition according to claim 7 is allowed to act on pests or their living environment.
10. A method for protecting plants from agricultural pests, characterized in that an isopropanolamine-containing capsaicin compound according to any one of claims 1-4 or a composition according to claim 7 is allowed to act on plants or their living environment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410034694.4A CN117886712A (en) | 2024-01-10 | 2024-01-10 | Isolamine-containing capsaicin compound, and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410034694.4A CN117886712A (en) | 2024-01-10 | 2024-01-10 | Isolamine-containing capsaicin compound, and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117886712A true CN117886712A (en) | 2024-04-16 |
Family
ID=90650350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410034694.4A Pending CN117886712A (en) | 2024-01-10 | 2024-01-10 | Isolamine-containing capsaicin compound, and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117886712A (en) |
-
2024
- 2024-01-10 CN CN202410034694.4A patent/CN117886712A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109627206B (en) | Preparation method and application of carbazolyl isopropanolamine derivatives with chiral centers | |
CN112608307B (en) | Heterocyclic substituted 1,3,4-oxadiazole hydrazide compound as well as preparation method and application thereof | |
CN111454260B (en) | 1,2,3,4-tetrahydro-beta-carboline compounds containing isopropanolamine substructure as well as preparation method and application thereof | |
CN110713512B (en) | Isopropanolamine substructure-containing glycyrrhetinic acid piperazine compounds and preparation method and application thereof | |
CN111548320A (en) | 1, 3, 4-oxadiazole hydrazide compounds and preparation method and application thereof | |
CN113636984B (en) | Morpholine group-containing 1,3, 4-oxadiazole compound and preparation method and application thereof | |
CN113461634B (en) | Thiazole hydrazide compound and preparation method and application thereof | |
US7491415B2 (en) | Fungicides compositions comprising the extract of Chloranthus henryi and a novel sesquiterpene compound isolated from them | |
CN112624931A (en) | Pterostilbene amine compounds containing isopropanol aromatic ether structure and preparation method and application thereof | |
CN110776548B (en) | Acetoxy ursolic acid piperazine compounds containing isopropanolamine substructure as well as preparation method and application thereof | |
CN110642916B (en) | Ursolic acid ester compounds containing tertiary amine structure and preparation method and application thereof | |
CN115260046B (en) | Rosin acid ester compound and preparation method and application thereof | |
CN114605489B (en) | 18 beta-glycyrrhetinic acid amide compound containing isopropanolamine structure and preparation method and application thereof | |
CN114751885B (en) | Coumarin compound containing isopropanolamine structure and preparation method and application thereof | |
CN117886712A (en) | Isolamine-containing capsaicin compound, and preparation method and application thereof | |
JP2007530700A (en) | Novel cyclopentenedione antifungal compounds and methods of use thereof | |
CN115536543B (en) | Triclosan compound containing isopropanolamine structure and preparation method and application thereof | |
CN111393359A (en) | Pyridine salt-containing N- (cinnamoyl) -N' - (substituted) propyl hydrazide compound and preparation method and application thereof | |
CN113999222B (en) | Adamantyl oxadiazole-containing compound and preparation method and application thereof | |
CN114380802B (en) | Carbazolyl-containing imidazole salt compound, and preparation method and application thereof | |
CN114920793B (en) | Estrone compound containing isopropanolamine substructure, preparation method, composition and application | |
CN116730954A (en) | Isopropanolamine compound containing chalcone structure, and preparation method and application thereof | |
CN117186016A (en) | Benzotriazole compound, preparation method and application thereof | |
CN110407681B (en) | Dehydrogingerol derivative, preparation method and application thereof | |
CN117024333A (en) | Oxime ether compound containing styryl and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |